oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ROWAN #TheraSphere #Durvalumab #Tremelimumab #HCC
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ROWAN #TheraSphere #Durvalumab #Tremelimumab #HCC
#RiskManagement #QMS #PostMarketSurveillance
#RiskManagement #QMS #PostMarketSurveillance
Boston, MA, 02/11/2025
"On 02/13/25, at 1138 EST, the licensee, Beth Israel Deaconess Medical Center (Massachusetts license number: 60-0432) reported a medical event involving yttrium-90 Theraspheres (Manufacturer: Nordion BWXT ITG Canada, Inc.; Model: TheraSphere Y-90 glass […]
Boston, MA, 02/11/2025
"On 02/13/25, at 1138 EST, the licensee, Beth Israel Deaconess Medical Center (Massachusetts license number: 60-0432) reported a medical event involving yttrium-90 Theraspheres (Manufacturer: Nordion BWXT ITG Canada, Inc.; Model: TheraSphere Y-90 glass […]
#RegulatoryAffairs #Traceability #SupplierQuality
#RegulatoryAffairs #Traceability #SupplierQuality
#Diagnostics #ClinicalValidation #PrimaryCare
#Diagnostics #ClinicalValidation #PrimaryCare
#ChangeControl #FDACompliance #MedTech
#ChangeControl #FDACompliance #MedTech
#MedTech #PostMarketSurveillance #FDA
#MedTech #PostMarketSurveillance #FDA
#MedDevice #FDA #PostMarketSurveillance
#MedDevice #FDA #PostMarketSurveillance
Charleston, WV, 05/21/2026
On May 21, 2026, at 1203 EDT, a Y-90 TheraSphere treatment was ordered for a patient. The doctor prescribed an activity of 3.98 GBq for a desired dose of 65 Gy to the liver. After administration, the activity received was calculated to be 3.68 GBq (92.5 […]
Charleston, WV, 05/21/2026
On May 21, 2026, at 1203 EDT, a Y-90 TheraSphere treatment was ordered for a patient. The doctor prescribed an activity of 3.98 GBq for a desired dose of 65 Gy to the liver. After administration, the activity received was calculated to be 3.68 GBq (92.5 […]
Madison, WI, 03/04/2026
"The University of Wisconsin Madison (UWM) reported an equipment failure involving a Y-90 TheraSphere microsphere administration set (lot A182) which occurred on March 4, 2026. UWM reported the tubing was damaged when it was removed from the priming line […]
Madison, WI, 03/04/2026
"The University of Wisconsin Madison (UWM) reported an equipment failure involving a Y-90 TheraSphere microsphere administration set (lot A182) which occurred on March 4, 2026. UWM reported the tubing was damaged when it was removed from the priming line […]
Newark, DE, 02/25/2026
A patient was undergoing a Y-90 TheraSphere therapy procedure. The treatment had an issue during the infusion procedure which resulted in an actual dose that was 58 percent of the prescribed dose. The target organ was the liver, and the prescribed activity […]
Newark, DE, 02/25/2026
A patient was undergoing a Y-90 TheraSphere therapy procedure. The treatment had an issue during the infusion procedure which resulted in an actual dose that was 58 percent of the prescribed dose. The target organ was the liver, and the prescribed activity […]
Philadelphia, PA, 12/12/2025
"On December 12, 2025, a patient was receiving a Y-90 TheraSphere treatment. The prescribed dose was 131.08 mCi. The patient received a dose of 72.4 mCi. No effect on the patient occurred.
"It is suspected that the cause was either the use of a […]
Philadelphia, PA, 12/12/2025
"On December 12, 2025, a patient was receiving a Y-90 TheraSphere treatment. The prescribed dose was 131.08 mCi. The patient received a dose of 72.4 mCi. No effect on the patient occurred.
"It is suspected that the cause was either the use of a […]